+1 347 708 0418
Seasonal Affective Disorder Therapeutics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Seasonal Affective Disorder Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Light Therapy (Phototherapy)
Medication
Others
Segment by Application
Hospitals
Clinics
Others
By Company
Allergan
Pfizer
Roche
Eli Lily
GlaxoSmithKline
Teva Pharmaceuticals
Bausch Health Companies
Mylan
Sanofi
Novartis
Johnson & Johnson
Koninklijke Philips
Beurer GmbH
Lucimed (Luminette)
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Seasonal Affective Disorder Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Light Therapy (Phototherapy)
1.2.3 Medication
1.2.4 Others
1.3 Market by Application
1.3.1 Global Seasonal Affective Disorder Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Seasonal Affective Disorder Therapeutics Market Perspective (2017-2028)
2.2 Seasonal Affective Disorder Therapeutics Growth Trends by Region
2.2.1 Seasonal Affective Disorder Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Seasonal Affective Disorder Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Seasonal Affective Disorder Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Seasonal Affective Disorder Therapeutics Market Dynamics
2.3.1 Seasonal Affective Disorder Therapeutics Industry Trends
2.3.2 Seasonal Affective Disorder Therapeutics Market Drivers
2.3.3 Seasonal Affective Disorder Therapeutics Market Challenges
2.3.4 Seasonal Affective Disorder Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Seasonal Affective Disorder Therapeutics Players by Revenue
3.1.1 Global Top Seasonal Affective Disorder Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Seasonal Affective Disorder Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Seasonal Affective Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Seasonal Affective Disorder Therapeutics Revenue
3.4 Global Seasonal Affective Disorder Therapeutics Market Concentration Ratio
3.4.1 Global Seasonal Affective Disorder Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Seasonal Affective Disorder Therapeutics Revenue in 2021
3.5 Seasonal Affective Disorder Therapeutics Key Players Head office and Area Served
3.6 Key Players Seasonal Affective Disorder Therapeutics Product Solution and Service
3.7 Date of Enter into Seasonal Affective Disorder Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Seasonal Affective Disorder Therapeutics Breakdown Data by Type
4.1 Global Seasonal Affective Disorder Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Seasonal Affective Disorder Therapeutics Forecasted Market Size by Type (2023-2028)
5 Seasonal Affective Disorder Therapeutics Breakdown Data by Application
5.1 Global Seasonal Affective Disorder Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Seasonal Affective Disorder Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Seasonal Affective Disorder Therapeutics Market Size (2017-2028)
6.2 North America Seasonal Affective Disorder Therapeutics Market Size by Type
6.2.1 North America Seasonal Affective Disorder Therapeutics Market Size by Type (2017-2022)
6.2.2 North America Seasonal Affective Disorder Therapeutics Market Size by Type (2023-2028)
6.2.3 North America Seasonal Affective Disorder Therapeutics Market Share by Type (2017-2028)
6.3 North America Seasonal Affective Disorder Therapeutics Market Size by Application
6.3.1 North America Seasonal Affective Disorder Therapeutics Market Size by Application (2017-2022)
6.3.2 North America Seasonal Affective Disorder Therapeutics Market Size by Application (2023-2028)
6.3.3 North America Seasonal Affective Disorder Therapeutics Market Share by Application (2017-2028)
6.4 North America Seasonal Affective Disorder Therapeutics Market Size by Country
6.4.1 North America Seasonal Affective Disorder Therapeutics Market Size by Country (2017-2022)
6.4.2 North America Seasonal Affective Disorder Therapeutics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Seasonal Affective Disorder Therapeutics Market Size (2017-2028)
7.2 Europe Seasonal Affective Disorder Therapeutics Market Size by Type
7.2.1 Europe Seasonal Affective Disorder Therapeutics Market Size by Type (2017-2022)
7.2.2 Europe Seasonal Affective Disorder Therapeutics Market Size by Type (2023-2028)
7.2.3 Europe Seasonal Affective Disorder Therapeutics Market Share by Type (2017-2028)
7.3 Europe Seasonal Affective Disorder Therapeutics Market Size by Application
7.3.1 Europe Seasonal Affective Disorder Therapeutics Market Size by Application (2017-2022)
7.3.2 Europe Seasonal Affective Disorder Therapeutics Market Size by Application (2023-2028)
7.3.3 Europe Seasonal Affective Disorder Therapeutics Market Share by Application (2017-2028)
7.4 Europe Seasonal Affective Disorder Therapeutics Market Size by Country
7.4.1 Europe Seasonal Affective Disorder Therapeutics Market Size by Country (2017-2022)
7.4.2 Europe Seasonal Affective Disorder Therapeutics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Seasonal Affective Disorder Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Seasonal Affective Disorder Therapeutics Market Size by Type
8.2.1 Asia-Pacific Seasonal Affective Disorder Therapeutics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Seasonal Affective Disorder Therapeutics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Seasonal Affective Disorder Therapeutics Market Share by Type (2017-2028)
8.3 Asia-Pacific Seasonal Affective Disorder Therapeutics Market Size by Application
8.3.1 Asia-Pacific Seasonal Affective Disorder Therapeutics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Seasonal Affective Disorder Therapeutics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Seasonal Affective Disorder Therapeutics Market Share by Application (2017-2028)
8.4 Asia-Pacific Seasonal Affective Disorder Therapeutics Market Size by Region
8.4.1 Asia-Pacific Seasonal Affective Disorder Therapeutics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Seasonal Affective Disorder Therapeutics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Seasonal Affective Disorder Therapeutics Market Size (2017-2028)
9.2 Latin America Seasonal Affective Disorder Therapeutics Market Size by Type
9.2.1 Latin America Seasonal Affective Disorder Therapeutics Market Size by Type (2017-2022)
9.2.2 Latin America Seasonal Affective Disorder Therapeutics Market Size by Type (2023-2028)
9.2.3 Latin America Seasonal Affective Disorder Therapeutics Market Share by Type (2017-2028)
9.3 Latin America Seasonal Affective Disorder Therapeutics Market Size by Application
9.3.1 Latin America Seasonal Affective Disorder Therapeutics Market Size by Application (2017-2022)
9.3.2 Latin America Seasonal Affective Disorder Therapeutics Market Size by Application (2023-2028)
9.3.3 Latin America Seasonal Affective Disorder Therapeutics Market Share by Application (2017-2028)
9.4 Latin America Seasonal Affective Disorder Therapeutics Market Size by Country
9.4.1 Latin America Seasonal Affective Disorder Therapeutics Market Size by Country (2017-2022)
9.4.2 Latin America Seasonal Affective Disorder Therapeutics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size by Type
10.2.1 Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Seasonal Affective Disorder Therapeutics Market Share by Type (2017-2028)
10.3 Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size by Application
10.3.1 Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Seasonal Affective Disorder Therapeutics Market Share by Application (2017-2028)
10.4 Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size by Country
10.4.1 Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Allergan Business Overview
11.1.3 Allergan Seasonal Affective Disorder Therapeutics Introduction
11.1.4 Allergan Revenue in Seasonal Affective Disorder Therapeutics Business (2017-2022)
11.1.5 Allergan Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Seasonal Affective Disorder Therapeutics Introduction
11.2.4 Pfizer Revenue in Seasonal Affective Disorder Therapeutics Business (2017-2022)
11.2.5 Pfizer Recent Developments
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Seasonal Affective Disorder Therapeutics Introduction
11.3.4 Roche Revenue in Seasonal Affective Disorder Therapeutics Business (2017-2022)
11.3.5 Roche Recent Developments
11.4 Eli Lily
11.4.1 Eli Lily Company Details
11.4.2 Eli Lily Business Overview
11.4.3 Eli Lily Seasonal Affective Disorder Therapeutics Introduction
11.4.4 Eli Lily Revenue in Seasonal Affective Disorder Therapeutics Business (2017-2022)
11.4.5 Eli Lily Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Seasonal Affective Disorder Therapeutics Introduction
11.5.4 GlaxoSmithKline Revenue in Seasonal Affective Disorder Therapeutics Business (2017-2022)
11.5.5 GlaxoSmithKline Recent Developments
11.6 Teva Pharmaceuticals
11.6.1 Teva Pharmaceuticals Company Details
11.6.2 Teva Pharmaceuticals Business Overview
11.6.3 Teva Pharmaceuticals Seasonal Affective Disorder Therapeutics Introduction
11.6.4 Teva Pharmaceuticals Revenue in Seasonal Affective Disorder Therapeutics Business (2017-2022)
11.6.5 Teva Pharmaceuticals Recent Developments
11.7 Bausch Health Companies
11.7.1 Bausch Health Companies Company Details
11.7.2 Bausch Health Companies Business Overview
11.7.3 Bausch Health Companies Seasonal Affective Disorder Therapeutics Introduction
11.7.4 Bausch Health Companies Revenue in Seasonal Affective Disorder Therapeutics Business (2017-2022)
11.7.5 Bausch Health Companies Recent Developments
11.8 Mylan
11.8.1 Mylan Company Details
11.8.2 Mylan Business Overview
11.8.3 Mylan Seasonal Affective Disorder Therapeutics Introduction
11.8.4 Mylan Revenue in Seasonal Affective Disorder Therapeutics Business (2017-2022)
11.8.5 Mylan Recent Developments
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Seasonal Affective Disorder Therapeutics Introduction
11.9.4 Sanofi Revenue in Seasonal Affective Disorder Therapeutics Business (2017-2022)
11.9.5 Sanofi Recent Developments
11.10 Novartis
11.10.1 Novartis Company Details
11.10.2 Novartis Business Overview
11.10.3 Novartis Seasonal Affective Disorder Therapeutics Introduction
11.10.4 Novartis Revenue in Seasonal Affective Disorder Therapeutics Business (2017-2022)
11.10.5 Novartis Recent Developments
11.11 Johnson & Johnson
11.11.1 Johnson & Johnson Company Details
11.11.2 Johnson & Johnson Business Overview
11.11.3 Johnson & Johnson Seasonal Affective Disorder Therapeutics Introduction
11.11.4 Johnson & Johnson Revenue in Seasonal Affective Disorder Therapeutics Business (2017-2022)
11.11.5 Johnson & Johnson Recent Developments
11.12 Koninklijke Philips
11.12.1 Koninklijke Philips Company Details
11.12.2 Koninklijke Philips Business Overview
11.12.3 Koninklijke Philips Seasonal Affective Disorder Therapeutics Introduction
11.12.4 Koninklijke Philips Revenue in Seasonal Affective Disorder Therapeutics Business (2017-2022)
11.12.5 Koninklijke Philips Recent Developments
11.13 Beurer GmbH
11.13.1 Beurer GmbH Company Details
11.13.2 Beurer GmbH Business Overview
11.13.3 Beurer GmbH Seasonal Affective Disorder Therapeutics Introduction
11.13.4 Beurer GmbH Revenue in Seasonal Affective Disorder Therapeutics Business (2017-2022)
11.13.5 Beurer GmbH Recent Developments
11.14 Lucimed (Luminette)
11.14.1 Lucimed (Luminette) Company Details
11.14.2 Lucimed (Luminette) Business Overview
11.14.3 Lucimed (Luminette) Seasonal Affective Disorder Therapeutics Introduction
11.14.4 Lucimed (Luminette) Revenue in Seasonal Affective Disorder Therapeutics Business (2017-2022)
11.14.5 Lucimed (Luminette) Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Seasonal Affective Disorder Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Light Therapy (Phototherapy)
Table 3. Key Players of Medication
Table 4. Key Players of Others
Table 5. Global Seasonal Affective Disorder Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Seasonal Affective Disorder Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Seasonal Affective Disorder Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Seasonal Affective Disorder Therapeutics Market Share by Region (2017-2022)
Table 9. Global Seasonal Affective Disorder Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Seasonal Affective Disorder Therapeutics Market Share by Region (2023-2028)
Table 11. Seasonal Affective Disorder Therapeutics Market Trends
Table 12. Seasonal Affective Disorder Therapeutics Market Drivers
Table 13. Seasonal Affective Disorder Therapeutics Market Challenges
Table 14. Seasonal Affective Disorder Therapeutics Market Restraints
Table 15. Global Seasonal Affective Disorder Therapeutics Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Seasonal Affective Disorder Therapeutics Revenue Share by Players (2017-2022)
Table 17. Global Top Seasonal Affective Disorder Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Seasonal Affective Disorder Therapeutics as of 2021)
Table 18. Ranking of Global Top Seasonal Affective Disorder Therapeutics Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Seasonal Affective Disorder Therapeutics Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Seasonal Affective Disorder Therapeutics Product Solution and Service
Table 22. Date of Enter into Seasonal Affective Disorder Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Seasonal Affective Disorder Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Seasonal Affective Disorder Therapeutics Revenue Market Share by Type (2017-2022)
Table 26. Global Seasonal Affective Disorder Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Seasonal Affective Disorder Therapeutics Revenue Market Share by Type (2023-2028)
Table 28. Global Seasonal Affective Disorder Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Seasonal Affective Disorder Therapeutics Revenue Share by Application (2017-2022)
Table 30. Global Seasonal Affective Disorder Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Seasonal Affective Disorder Therapeutics Revenue Share by Application (2023-2028)
Table 32. North America Seasonal Affective Disorder Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Seasonal Affective Disorder Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Seasonal Affective Disorder Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Seasonal Affective Disorder Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Seasonal Affective Disorder Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Seasonal Affective Disorder Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Seasonal Affective Disorder Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Seasonal Affective Disorder Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Seasonal Affective Disorder Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Seasonal Affective Disorder Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Seasonal Affective Disorder Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Seasonal Affective Disorder Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Seasonal Affective Disorder Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Seasonal Affective Disorder Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Seasonal Affective Disorder Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Seasonal Affective Disorder Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Seasonal Affective Disorder Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Seasonal Affective Disorder Therapeutics Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Seasonal Affective Disorder Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Seasonal Affective Disorder Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Seasonal Affective Disorder Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Seasonal Affective Disorder Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Seasonal Affective Disorder Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Seasonal Affective Disorder Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Seasonal Affective Disorder Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Seasonal Affective Disorder Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Seasonal Affective Disorder Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Seasonal Affective Disorder Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Seasonal Affective Disorder Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Seasonal Affective Disorder Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 62. Allergan Company Details
Table 63. Allergan Business Overview
Table 64. Allergan Seasonal Affective Disorder Therapeutics Product
Table 65. Allergan Revenue in Seasonal Affective Disorder Therapeutics Business (2017-2022) & (US$ Million)
Table 66. Allergan Recent Developments
Table 67. Pfizer Company Details
Table 68. Pfizer Business Overview
Table 69. Pfizer Seasonal Affective Disorder Therapeutics Product
Table 70. Pfizer Revenue in Seasonal Affective Disorder Therapeutics Business (2017-2022) & (US$ Million)
Table 71. Pfizer Recent Developments
Table 72. Roche Company Details
Table 73. Roche Business Overview
Table 74. Roche Seasonal Affective Disorder Therapeutics Product
Table 75. Roche Revenue in Seasonal Affective Disorder Therapeutics Business (2017-2022) & (US$ Million)
Table 76. Roche Recent Developments
Table 77. Eli Lily Company Details
Table 78. Eli Lily Business Overview
Table 79. Eli Lily Seasonal Affective Disorder Therapeutics Product
Table 80. Eli Lily Revenue in Seasonal Affective Disorder Therapeutics Business (2017-2022) & (US$ Million)
Table 81. Eli Lily Recent Developments
Table 82. GlaxoSmithKline Company Details
Table 83. GlaxoSmithKline Business Overview
Table 84. GlaxoSmithKline Seasonal Affective Disorder Therapeutics Product
Table 85. GlaxoSmithKline Revenue in Seasonal Affective Disorder Therapeutics Business (2017-2022) & (US$ Million)
Table 86. GlaxoSmithKline Recent Developments
Table 87. Teva Pharmaceuticals Company Details
Table 88. Teva Pharmaceuticals Business Overview
Table 89. Teva Pharmaceuticals Seasonal Affective Disorder Therapeutics Product
Table 90. Teva Pharmaceuticals Revenue in Seasonal Affective Disorder Therapeutics Business (2017-2022) & (US$ Million)
Table 91. Teva Pharmaceuticals Recent Developments
Table 92. Bausch Health Companies Company Details
Table 93. Bausch Health Companies Business Overview
Table 94. Bausch Health Companies Seasonal Affective Disorder Therapeutics Product
Table 95. Bausch Health Companies Revenue in Seasonal Affective Disorder Therapeutics Business (2017-2022) & (US$ Million)
Table 96. Bausch Health Companies Recent Developments
Table 97. Mylan Company Details
Table 98. Mylan Business Overview
Table 99. Mylan Seasonal Affective Disorder Therapeutics Product
Table 100. Mylan Revenue in Seasonal Affective Disorder Therapeutics Business (2017-2022) & (US$ Million)
Table 101. Mylan Recent Developments
Table 102. Sanofi Company Details
Table 103. Sanofi Business Overview
Table 104. Sanofi Seasonal Affective Disorder Therapeutics Product
Table 105. Sanofi Revenue in Seasonal Affective Disorder Therapeutics Business (2017-2022) & (US$ Million)
Table 106. Sanofi Recent Developments
Table 107. Novartis Company Details
Table 108. Novartis Business Overview
Table 109. Novartis Seasonal Affective Disorder Therapeutics Product
Table 110. Novartis Revenue in Seasonal Affective Disorder Therapeutics Business (2017-2022) & (US$ Million)
Table 111. Novartis Recent Developments
Table 112. Johnson & Johnson Company Details
Table 113. Johnson & Johnson Business Overview
Table 114. Johnson & Johnson Seasonal Affective Disorder Therapeutics Product
Table 115. Johnson & Johnson Revenue in Seasonal Affective Disorder Therapeutics Business (2017-2022) & (US$ Million)
Table 116. Johnson & Johnson Recent Developments
Table 117. Koninklijke Philips Company Details
Table 118. Koninklijke Philips Business Overview
Table 119. Koninklijke Philips Seasonal Affective Disorder Therapeutics Product
Table 120. Koninklijke Philips Revenue in Seasonal Affective Disorder Therapeutics Business (2017-2022) & (US$ Million)
Table 121. Koninklijke Philips Recent Developments
Table 122. Beurer GmbH Company Details
Table 123. Beurer GmbH Business Overview
Table 124. Beurer GmbH Seasonal Affective Disorder Therapeutics Product
Table 125. Beurer GmbH Revenue in Seasonal Affective Disorder Therapeutics Business (2017-2022) & (US$ Million)
Table 126. Beurer GmbH Recent Developments
Table 127. Lucimed (Luminette) Company Details
Table 128. Lucimed (Luminette) Business Overview
Table 129. Lucimed (Luminette) Seasonal Affective Disorder Therapeutics Product
Table 130. Lucimed (Luminette) Revenue in Seasonal Affective Disorder Therapeutics Business (2017-2022) & (US$ Million)
Table 131. Lucimed (Luminette) Recent Developments
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Seasonal Affective Disorder Therapeutics Market Share by Type: 2021 VS 2028
Figure 2. Light Therapy (Phototherapy) Features
Figure 3. Medication Features
Figure 4. Others Features
Figure 5. Global Seasonal Affective Disorder Therapeutics Market Share by Application: 2021 VS 2028
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Seasonal Affective Disorder Therapeutics Report Years Considered
Figure 10. Global Seasonal Affective Disorder Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Seasonal Affective Disorder Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Seasonal Affective Disorder Therapeutics Market Share by Region: 2021 VS 2028
Figure 13. Global Seasonal Affective Disorder Therapeutics Market Share by Players in 2021
Figure 14. Global Top Seasonal Affective Disorder Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Seasonal Affective Disorder Therapeutics as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Seasonal Affective Disorder Therapeutics Revenue in 2021
Figure 16. North America Seasonal Affective Disorder Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Seasonal Affective Disorder Therapeutics Market Size Market Share by Type (2017-2028)
Figure 18. North America Seasonal Affective Disorder Therapeutics Market Size Market Share by Application (2017-2028)
Figure 19. North America Seasonal Affective Disorder Therapeutics Market Size Share by Country (2017-2028)
Figure 20. United States Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Seasonal Affective Disorder Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Seasonal Affective Disorder Therapeutics Market Size Market Share by Type (2017-2028)
Figure 24. Europe Seasonal Affective Disorder Therapeutics Market Size Market Share by Application (2017-2028)
Figure 25. Europe Seasonal Affective Disorder Therapeutics Market Size Share by Country (2017-2028)
Figure 26. Germany Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Seasonal Affective Disorder Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Seasonal Affective Disorder Therapeutics Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Seasonal Affective Disorder Therapeutics Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Seasonal Affective Disorder Therapeutics Market Size Share by Region (2017-2028)
Figure 36. China Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 42. Latin America Seasonal Affective Disorder Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Seasonal Affective Disorder Therapeutics Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Seasonal Affective Disorder Therapeutics Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Seasonal Affective Disorder Therapeutics Market Size Share by Country (2017-2028)
Figure 46. Mexico Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Seasonal Affective Disorder Therapeutics Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Seasonal Affective Disorder Therapeutics Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Seasonal Affective Disorder Therapeutics Market Size Share by Country (2017-2028)
Figure 52. Turkey Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Allergan Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2017-2022)
Figure 56. Pfizer Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2017-2022)
Figure 57. Roche Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2017-2022)
Figure 58. Eli Lily Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2017-2022)
Figure 59. GlaxoSmithKline Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2017-2022)
Figure 60. Teva Pharmaceuticals Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2017-2022)
Figure 61. Bausch Health Companies Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2017-2022)
Figure 62. Mylan Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2017-2022)
Figure 63. Sanofi Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2017-2022)
Figure 64. Novartis Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2017-2022)
Figure 65. Johnson & Johnson Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2017-2022)
Figure 66. Koninklijke Philips Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2017-2022)
Figure 67. Beurer GmbH Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2017-2022)
Figure 68. Lucimed (Luminette) Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2017-2022)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Buy
